. Author manuscript; available in PMC: 2023 Jul 1.

Published in final edited form as: Heart Fail Clin. 2022 Jul;18(3):479–488. doi: 10.1016/j.hfc.2022.02.005

Table 2.

Staging systems cardiac amyloidosis

AL	Points	Stage	Median Survival, mo.
	0	I	>120
	1	II	69
	2	III	16
	3	IV	6

ATTR	0	I	69.2
	1	II	46.7
	2	III	24.1

AL 1 point each for dFLC >180mg/L; NTproBNP >1800 pg./mL; HS TroponinT ≥40ng/L(61)

ATTR 1 point each for NTproBNP>300ng/L; eGFR<45 mL/min(62)